Learn more about Capital

Capital

Capital Solutions in the New Health

Today’s bio pharma companies are under increased pressure to:

  • Speed drug development and commercialization
  • Meet demanding regulatory requirements
  • Access resistant markets and;
  • Maximize value across the product lifecycle – while reducing financial and operational risks

You need an ally with global reach, broad experience and scientific expertise who can expand opportunities and mitigate risk strategically and operationally.

As a fully integrated bio pharma services company, Quintiles ensures alignment with sponsor needs by defining shared goals, risks and rewards, and implementing proven governance principles that deliver innovative, cost-effective solutions.

Innovative Alliances

We leverage our intellectual, human and financial capital to advance mutual interests and accomplish shared goals.

Quintiles:

  • Has more than $2.4 billion in investment commitments
  • Drives 80+ non-traditional alliances;
  • Manages over 4,000 employees for our partners

We’re as motivated to achieve goals as you are with -

Intellectual Capital – With an integrated approach, we work with you to solve business challenges and shape programs with less risk and variability, and a greater likelihood of success.

Human Capital – We can optimize drug development and drive commercial success with the thousands of clinical and commercial experts across therapeutic disciplines around the world.

Financial Capital – As your partner we invest our financial resources into your programs, as well as find and manage interested capital partners.


 
Partnership Structures

Support your business initiative with resources and expertise.

Late Phase

Demonstrate product benefits and monitor safety in larger populations with cost-effective study design and execution.

Alliance Management

Transform large fixed costs into variable as-needed resources.

Partnership Case Studies

These case studies demonstrate just a few of our innovative solutions that go beyond the traditional fee-for-service model.

Contact Us

Capital

US: 1 866 267 4479
Intl: Click for toll-free access by country

White Paper

The New Health Alliance

Biopharmaceutical companies must explore alternative strategic alliances that meet the needs of the New Health and produce medicines that demonstrate value to the entire constellation of stakeholders.

Read more

Managing Alliances with the Balanced Scorecard

Recent Harvard Business Review article highlights Quintiles’ strategic partnering success.

Download here

Recent Strategic Alliances

From driving early phase decision-making to helping develop oncology compounds, these recent alliances demonstrate how Quintiles helps customers create more valuable business models.
AstraZeneca
Eisai Co., Ltd.
Allergan